NasdaqGM - Nasdaq Real Time Price USD
Inventiva S.A. (IVA)
3.7000
-0.1300
(-3.39%)
As of 12:46:09 PM EDT. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-85,928
-85,928
-81,614
-44,928
-47,629
Investing Cash Flow
8,745
8,745
-7,731
8,868
-1,793
Financing Cash Flow
145,592
145,592
29,081
37,268
25,447
End Cash Position
96,564
96,564
26,918
86,736
86,553
Capital Expenditure
-333
-333
-540
-561
-534
Issuance of Capital Stock
57,338
57,338
30,589
8,827
25,475
Issuance of Debt
24,916
24,916
--
30,209
--
Repayment of Debt
-4,992
-4,992
-4,097
-1,768
-28
Free Cash Flow
-86,261
-86,261
-82,154
-45,489
-48,163
12/31/2021 - 7/10/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ELTX Elicio Therapeutics, Inc.
5.20
-0.38%
ADAG Adagene Inc.
1.3900
-2.80%
ABVX ABIVAX Société Anonyme
7.26
+7.32%
BIOR Biora Therapeutics, Inc.
0.2200
0.00%
AMPE Ampio Pharmaceuticals, Inc.
0.0217
-0.23%
NTHI NeOnc Technologies Holdings, Inc. Common Stock
5.84
-0.68%
IMCR Immunocore Holdings plc
30.16
+1.21%
NXOA.BE Nicox SA
0.2260
0.00%
BT3.BE Lineage Cell Therapeutics Inc
0.4020
+8.06%
HQ1.MU Oruka Therapeutics Inc. R
9.15
+0.55%